Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec;129(12):1949-1955.
doi: 10.1038/s41416-023-02480-y. Epub 2023 Nov 6.

Radiomics-based decision support tool assists radiologists in small lung nodule classification and improves lung cancer early diagnosis

Affiliations

Radiomics-based decision support tool assists radiologists in small lung nodule classification and improves lung cancer early diagnosis

Benjamin Hunter et al. Br J Cancer. 2023 Dec.

Abstract

Background: Methods to improve stratification of small (≤15 mm) lung nodules are needed. We aimed to develop a radiomics model to assist lung cancer diagnosis.

Methods: Patients were retrospectively identified using health records from January 2007 to December 2018. The external test set was obtained from the national LIBRA study and a prospective Lung Cancer Screening programme. Radiomics features were extracted from multi-region CT segmentations using TexLab2.0. LASSO regression generated the 5-feature small nodule radiomics-predictive-vector (SN-RPV). K-means clustering was used to split patients into risk groups according to SN-RPV. Model performance was compared to 6 thoracic radiologists. SN-RPV and radiologist risk groups were combined to generate "Safety-Net" and "Early Diagnosis" decision-support tools.

Results: In total, 810 patients with 990 nodules were included. The AUC for malignancy prediction was 0.85 (95% CI: 0.82-0.87), 0.78 (95% CI: 0.70-0.85) and 0.78 (95% CI: 0.59-0.92) for the training, test and external test datasets, respectively. The test set accuracy was 73% (95% CI: 65-81%) and resulted in 66.67% improvements in potentially missed [8/12] or delayed [6/9] cancers, compared to the radiologist with performance closest to the mean of six readers.

Conclusions: SN-RPV may provide net-benefit in terms of earlier cancer diagnosis.

PubMed Disclaimer

Conflict of interest statement

Professor Devaraj reports personal fees from Brainomix, Roche, and Boehringer Ingelheim and has stock options in Brainomix. Dr Lee is funded by the Royal Marsden NIHR BRC, Royal Marsden Cancer Charity and SBRI (including QURE.AI). RL’s institution receives compensation for time spent in a secondment role for the lung health check programme and as a National Specialty Lead for the National Institute of Health and Care Research. He has received research funding from CRUK, Innovate UK (co-funded by GE Healthcare, Roche and Optellum), SBRI, RM Partners Cancer Alliance and NIHR (co-applicant in grants with Optellum). He has received honoraria from CRUK. The remaining authors declare no competing interests.

Figures

Fig. 1
Fig. 1. Recruitment diagram and segmentation labels.
a Study recruitment diagram. Databases of lung histopathology (n = 1450) and lung nodule MDT records (n = 927) were used to identify eligible patients. Following exclusion based on eligibility criteria (n = 1723) and technical limitations of CT images (n = 21), the final internal dataset consisted of 633 patients with 736 nodules. b Cropped, axial plane CT images showing binary segmentation masks (red) for nodule regions. The primary lung nodule was segmented (1) and then expanded by 2 mm isotropically to create a spherical annulus structure (2). An 8 × 8 mm spherical background structure (3) was segmented 15 mm away from the primary lesion.
Fig. 2
Fig. 2. Decision-support tool scenarios.
In cases where the radiologist categorises a nodule as low-risk, a high-risk SN-RPV triggers the “Safety Net”, prompting earlier surveillance or investigation. In cases where the radiologist classifies a nodule as indeterminate, a high-risk SN-RPV triggers the “Early Diagnosis” pathway, prompting further investigation rather than surveillance. Cases evaluated as high-risk by the radiologist are not affected by the proposed decision support method.

References

    1. Gould MK, Tang T, Liu ILA, Lee J, Zheng C, Danforth KN, et al. Recent trends in the identification of incidental pulmonary nodules. Am J Respir Crit Care Med. 2015;192:1208–14. doi: 10.1164/rccm.201505-0990OC. - DOI - PubMed
    1. Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365:395–409. doi: 10.1056/NEJMoa1102873. - DOI - PMC - PubMed
    1. Larici AR, Farchione A, Franchi P, Ciliberto M, Cicchetti G, Calandriello L, et al. Lung nodules: size still matters. Eur Respir Rev. 2017;26:170025. doi: 10.1183/16000617.0025-2017. - DOI - PMC - PubMed
    1. Baldwin DR, Callister MEJ. The British Thoracic Society guidelines on the investigation and management of pulmonary nodules. Thorax. 2015;70:794–8. doi: 10.1136/thoraxjnl-2015-207221. - DOI - PubMed
    1. Lam S, Bryant H, Donahoe L, Domingo A, Earle C, Finley C, et al. Management of screen-detected lung nodules: a Canadian partnership against cancer guidance document. Can J Respir Crit Care Sleep Med. 2020;4:236–65.

Publication types

LinkOut - more resources